1. Home
  2. CHMI vs ARMP Comparison

CHMI vs ARMP Comparison

Compare CHMI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

N/A

Current Price

$2.88

Market Cap

108.3M

Sector

Real Estate

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$4.37

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHMI
ARMP
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.3M
199.7M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
CHMI
ARMP
Price
$2.88
$4.37
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.00
$15.00
AVG Volume (30 Days)
268.8K
234.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
15.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$61.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$2.88
52 Week High
$2.98
$14.98

Technical Indicators

Market Signals
Indicator
CHMI
ARMP
Relative Strength Index (RSI) 53.24 39.56
Support Level $2.55 $3.98
Resistance Level $2.98 $5.63
Average True Range (ATR) 0.04 0.57
MACD -0.03 -0.06
Stochastic Oscillator 23.53 7.05

Price Performance

Historical Comparison
CHMI
ARMP

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: